Clinical Trial Results: N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use [Phase 4]

View source ↗

Summary

Phase 4 trial assessing N-Acetylcysteine for smoking cessation in individuals using tobacco and cannabis; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder
• Drug Use Disorder
• Tobacco Use Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Ellen Herbst | Conditions: Cannabis Use, Tobacco Use Disorder | Phase 4 | Status: COMPLETED | Results posted: 2026-08-11